Occult Carcinoma in Prophylactic Oophorectomy Specimens
Top Cited Papers
- 1 October 2001
- journal article
- research article
- Published by Wolters Kluwer Health in The American Journal of Surgical Pathology
- Vol. 25 (10) , 1283-1289
- https://doi.org/10.1097/00000478-200110000-00009
Abstract
Prophylactic oophorectomy (PO) is an option for women at increased risk for ovarian carcinoma. In this study the value of intensive pathologic examination of PO specimens and accompanying resected tissues in the identification of occult carcinoma and any association of occult carcinoma with BRCA germline mutation status were ascertained. Specimens from 60 consecutive PO patients, who were not suspected of having any ovarian tumor at the time of surgery, were subjected to standardized, complete pathologic examination in a prospective study over an 8-year period. Extra-ovarian tissues were examined as well, but they were not subject to the same standardized protocol. Any occult carcinoma of the ovaries or fallopian tubes was noted. The BRCA status and follow-up of patients were obtained, if available. Fifty-five of the 60 PO specimens did not show any evidence of malignancy. Of the 32 patients in this group followed for >1 year, all are alive and well. The remaining five patients, all BRCA1 mutation positive, showed occult carcinoma of the ovaries and/or in situ or invasive carcinoma of a fallopian tube. One of these five patients has died of abdominal carcinomatosis; four continue to be well, but follow-up is <4 years in all cases. Occult carcinoma is present in a small proportion of BRCA-positive or unknown PO patients and may be of prognostic significance. The entire ovaries and tubes from PO patients should be submitted for histologic examination to identify malignancy.Keywords
This publication has 36 references indexed in Scilit:
- A Genetic Epidemiological Study of Carcinoma of the Fallopian TubeGynecologic Oncology, 2001
- Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?Gynecologic Oncology, 2000
- BRCA1 germline mutations in women with uterine serous papillary carcinomaObstetrics & Gynecology, 2000
- Ovarian dysplasia in prophylactic oophorectomy specimensCancer, 1999
- Comparison of Prophylactic Oophorectomy Specimens From Carriers and Noncarriers of a BRCA1 or BRCA2 Gene MutationJNCI Journal of the National Cancer Institute, 1999
- Histopathologic Features of Ovaries at Increased Risk for CarcinomaInternational Journal of Gynecological Pathology, 1999
- Tumors of the Fimbriated End of the Fallopian TubeInternational Journal of Gynecological Pathology, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies ConsortiumPublished by American Medical Association (AMA) ,1997
- Pathology of Early Malignant Change in the OvaryInternational Journal of Gynecological Pathology, 1993